{"name":"Acrivon Therapeutics","slug":"acrivon-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE53NU8tR080TGxIX3JsZzVKMzFmRzdXeW9HTnY0dHE4SXhmbHRpSHBTR0tJUENLUVBJSzFSTHpnRTRiQXlxSjhVOHVVSDY0d1RMQXB0OHlSWk9ma3JvYkdIaVJrQURLdDZlM1VUQjBR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Acrivon Therapeutics, Inc. (ACRV) - Stock Titan","headline":"If You Invested $1,000 in Acrivon Therapeutics, Inc. (ACRV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxPMk40OHRyNlhSMXMzM1RyZ19vSWp0eWs4MEZoR0lCMm02UkJ4X2VDYkM4NFg1dDlTbGVkSTNoN2NJMFZQN19PRkN2Zk1oQzh2TzA1bS1hWk5SajhxcFpTOGdFSnZCcDBjSjc0akJaU3dvTE5yV19qRG1DcjlQWUl4NDNQbUk1LVFiclZGaUJMc2Z6M05vYTJNOXJxQ3h0cjRod2hac21yWkhQQmoxbjFMZXByalBXeE5mUXFYVi15QWpIWkRTMFdpYVA3UXIwUHpWN1JzOHFKdFpHMzRYeDJuZnNUQ1IwQjhOc1V0NWFEaXU0cDFBSFpDa25MMFBfWHgtcnhrN1luUHB6cmNqZGNlajdtbnlTYVNITFhoZXVKZld6Slh0VDA1NzI0RTkwcjN6b1pNN2FxaUoyS0c0M3ZqbXBOaG0?oc=5","date":"2026-03-21","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Scholar Rock Holding (SRRK) and Acrivon Therapeutics, Inc. (ACRV) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Scholar Rock Holding (SRRK) and Acriv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE80NGNTbTZtSFRQdi1YVkNhQVhWVk9DWUZPMzhSZzcxbG8weWRHRlVYZTJJeU1fNG9NRXcxenRVM243V2l0VnlzNGpLQVQ4TlJZVXpQWktKXzlZWGc1RTNj?oc=5","date":"2026-01-16","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-02","type":"pipeline","source":"simplywall.st","summary":"Spotlight On 3 Promising Penny Stocks With Over $50M Market Cap - simplywall.st","headline":"Spotlight On 3 Promising Penny Stocks With Over $50M Market Cap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1TRnI5LUltMEtoVjRQTVNLQ3BoOTRfRGJLZnM4TGVqSDVubDlleWJzWl90X2swQVcwQWlOekVwd2xtam1oLWp1aEhUYzJZUVBuTVVMQnphODF6blBFNUZhMmp0ODVTMXc?oc=5","date":"2025-06-04","type":"pipeline","source":"MedPage Today","summary":"Win for Added Relacorilant in Platinum-Resistant Ovarian Cancer - MedPage Today","headline":"Win for Added Relacorilant in Platinum-Resistant Ovarian Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOZ1Zaam5fREhPUzVORzdMdHFwd3UxUWFpUy1fU0ZqSlJWaDg0ZS1JVVFCOXB1YlBrekpqb3ZkWlpWb08wZG1HU1VPaE9PbS0zWUlhLWptZnFtY01FdmwxcVFRU216aEhfdWxaRWFZbElKNGdIOF84M3B4WTE5amNuOHNoV3FVUkFFQWFSTVVpN09ScHZsTGdIOExXQ3A0ZUp6Y0dBMVBaRVZTOU9ibFRKNnJWUDRQZ1Ux?oc=5","date":"2025-03-26","type":"trial","source":"Fierce Biotech","summary":"Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial - Fierce Biotech","headline":"Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBEZVhEX0h2UDFRekFROVJpeE96akdyTXFrcV9YSHptbDY0VTJIMHlpTDhmc29vbFV4VW5FWlUzUmRQZjlZSXpGNEJJQ3RURHg0NHhsWDdScmVOLWZp?oc=5","date":"2024-04-09","type":"pipeline","source":"TradingView","summary":"ACRV Stock Price and Chart — NASDAQ:ACRV - TradingView","headline":"ACRV Stock Price and Chart — NASDAQ:ACRV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE0wOXBhbTZGaU9BRXFXRWZPOGxJRXctYlZWU3RmQWdXVWdObmxrWWY3MWZGWUkybEV2aVN0RFNlYjlzQ0ZMVURFWURTWGZYb0tr?oc=5","date":"2024-04-02","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9hWllfTExSeGowcU9oLW5sOGpmNnNDQ3F3R0xGUGNBMFpRN2h4M2p3Tk13SjZZbHRuYlJqWmJQT2ZheGV3Z0NwZ1VOdEpmRHZicTVvYWdGN2lXLThoY0lSN2lFT3F0QmRZUU9tTGswRWFBQ1ZaRGc?oc=5","date":"2024-03-07","type":"trial","source":"Oncology Pipeline","summary":"Boundless enthusiasm for CHK1 | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Boundless enthusiasm for CHK1 | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNaDZ4dUF2WVNqNzVvMDdnV3NTa1pwRkxhUVYzMmtSMUZad2Y0QWRQVGIxb1E1ZGJuYVhjTjM2M09JSUd1YjZEZ1ZkM2hxcU9Mc3dyVzdOUnBwWkxmcE9CcmtrMVlSN1RtQWxoWVhadVpqNW00NDJyb3Z5eUtKLTVQU3RyRThVWTllSDJJdzZkQ1dTMUtWQ3Z6cy1ydXVwTEREM2o2R2N1OGxGcEZybUkxQnBJVzRBcDlFY09NTW9sOVUwVEhNVkJXag?oc=5","date":"2023-08-23","type":"pipeline","source":"Precision Medicine Online","summary":"Acrivon Therapeutics Eyeing Precision Oncology Through Proteomics Lens - Precision Medicine Online","headline":"Acrivon Therapeutics Eyeing Precision Oncology Through Proteomics Lens","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBhUlAxT1pnVFFaSkxoVXhLbkpkWVJiTy1YSy1mdVN3OFphSGVycmVhY1djby1fWGlqQTdZejViMHRMVVZPRFhLWEUwOTJDRUVuLWJQUUV1dEFPMWluRUpPdlcwMl9zUDJJU2JUME1IMDZaaFNXZ0FtV3E0cWxMc2c?oc=5","date":"2022-11-15","type":"pipeline","source":"BioPharma Dive","summary":"Acrivon cuts IPO price to raise $99M for plan to revive old Lilly cancer drug - BioPharma Dive","headline":"Acrivon cuts IPO price to raise $99M for plan to revive old Lilly cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQRzFDX3kyaF9RcUR5cXh2Wm04LXlYMXlRUk1vdC1pVWtkQ2ZkQ2FuM1d4QXdHVkZTM1Y5clhtdExodVhIN3FuNm9JRWJFcXlRMW5EYlJZdjlQeEpPcUZXdHM4d0RLbHdyS1dRY2FPQzhDc1pDeEJmOXRacHE2MjZBd3BoUkFsUVE?oc=5","date":"2022-10-19","type":"pipeline","source":"BioPharma Dive","summary":"A startup plans an IPO to give a shelved Lilly drug another shot - BioPharma Dive","headline":"A startup plans an IPO to give a shelved Lilly drug another shot","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}